Clinical Epidemiology

Group leader: José Ignacio Emparanza, M.D., Ph.D.

Donostialdea IHO, CASP Spain, CIBER-ESP joseignacio.emparanza@osakidetza.eus

Strategic Objectives

  • To offer teaching in the following areas:
    • Research methodology.
    • Evidence-based healthcare.
    • Clinical decision-making.
  • To advise on the research process:
    • Designing research protocol.
    • Leading the study.
    • Collecting information.
    • Statistical analysis.
    • Disseminating results.
  • To design our own research projects on:
    • Diagnosis
    • Prognosis / Clinical prediction rules.
    • Treatment (randomised clinical trials).
  • To participate in:
    • Hospital structures to improve the effectiveness and efficiency of healthcare.
    • National and international Clinical Epidemiology and EBM.

Main lines of research

  • Clinical efficiency and effectiveness.
  • Research methodology.
  • Evidence-based medicine.

Team Members

 

Name Surname
Center E-mail
Maite Álvarez Frias Donostialdea IHO  
Eukene Ansuategui Zengotitabengoa Donostialdea IHO eukene.ansuateguicengotitab@osakidetza.eus
Pedro Aranegui Lasuen Donostialdea IHO pedro.araneguilasuen@osakidetza.eus
Jose María Arteche Ocasar Donostialdea IHO josemaria.artecheocasar@osakidetza.eus
Mª Teresa Callén Blecua Donostialdea IHO mariateresa.callenblecua@osakidetza.eus
Mª Teresa Iglesias Gaspar Donostialdea IHO mariateresa.iglesiasgaspar@osakidetza.eus
Mª Camino Martínez Andueza Donostialdea IHO camino.martinezandueza@osakidetza.eus
Juan Antonio Martínez Martínez Donostialdea IHO juanantonio.martinezmartinez@osakidetza.eus
Irene Ozcoidi Erro Donostialdea IHO irene.ozcoidierro@osakidetza.eus
Mª Del Mar Ubeda Carrillo Donostialdea IHO marimar.ubedacarrillo@osakidetza.eus
Iratxe Urreta Barallobre Donostialdea IHO iratxe.urretabarallobre@osakidetza.eus
Mª José Velázquez Zubikoa Donostialdea IHO mjose.velazquezzubicoa@osakidetza.eus
Xavier Zubeldia Caminos Donostialdea IHO  

Scientific Output

Originals

Published: 10 / 51

Epidemiology of asthma exacerbations and their relation with environmental factors in the Basque Country.

Altzibar JM, Tamayo-Uria I, De Castro V, Aginagalde X, Albizu MV, Lertxundi A, Benito J, Busca P, Antepara I, Landa J, Mokoroa O, Dorronsoro M.

Clin. Exp. Allergy. 2015; 45: 1099-1108. FI: 4.769 (Q1).

Gender and plasma iron biomarkers, but not HFE gene mutations, increase the risk of colorectal cancer and polyps.

Castiella A, Mugica F, Zapata E, Zubiaurre L, Iribarren A, de Juan MD, Alzate L, Gil I, Urdapilleta G, Otazua P, Emparanza JI.

Tumor Biol. 2015; 36: 6959-6963. FI: 3.611 (Q2).

Differences in practice among physicians staffing an emergency department in relation to years of experience.

Busca P, Inchaurza E, Illarramendi A, Urbina O, Gonzalez L, Miro O.

Emergencias. 2015; 27: 143-149. FI: 2.895 (Q1).

Quality of life in patients with non-muscle-invasive bladder cancer: One-year results of a multicentre prospective cohort study

Schmidt S, Francés A, Lorente Garin JA, Juanpere N, Lloreta Trull J, Bonfill X, Martinez-Zapata MJ, Morales Suarez-Varela M, de la Cruz J, Emparanza JI, Sánchez MJ, Zamora J, Pijoan JI, Alonso J, Ferrer M

Urol. Oncol.-Semin. Orig. Investig.2015; 33. FI: 2.768 (Q2).

Impact of H63D mutations, magnetic resonance and metabolic syndrome among outpatient referrals for elevated serum ferritin in the Basque Country.

Castiella A, Zapata E, Zubiaurre L, Alustiza JM, De Juan,MD, Iribarren A, Emparanza JI, Otazua P.

Ann. Hepatol. 2015; 14: 333-339. FI: 2.065 (Q3).

Inflammatory Patterns in Asthmatic Children Based on Alveolar Nitric Oxide Determination.

Corcuera-Elosegui P, Sardón-Prado O, Aldasoro-Ruiz A, Korta-Murua J, Mintegui-Aramburu J, Emparanza-Knorr JI, Pérez-Yarza EG.

Arch. Bronconeumol. 2015; 51: 279-284. FI: 1.823 (Q3).

Measurement of Liver Iron Concentration by MRI Is Reproducible.

Alustiza JM, Emparanza JI, Castiella A, Casado A, Garrido A, Aldazabal P, San Vicente M, Garcia N, Asensio AB, Banales J, Salvador E, Moyua A, Arozena X, Zarco M, Jauregui L, Vicente O.

Biomed Res. Int. 2015; 2015: 294024-0. FI: 1.579 (Q3).

Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: a multicentre observational study.

Bonfill X, Martinez-Zapata MJ, Vernooij RWM, Sanchez MJ, Morales M, de la Cruz J, Emparanza JI, Ferrer M, Pijoan, JI, Ramos-Goni JM, Palou J, Schmidt S, Abraira V, Zamora J, EMPARO-CU Study Grp.

BMC Urol. 2015; 15. FI: 1.413 (Q3).

Does evidence-based practice improve patient outcomes? An analysis of a natural experiment in a Spanish hospital.

Emparanza JI, Cabello JB, Burls AJ.

J Eval Clin Pract. 2015; 21: 1059-1065. FI: 1.084 (Q3).

Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery.

Jimenez-Agüero R, Emparanza JI, Beguiristain A, Bujanda L, Alustiza JM, Garcia E, Hijona E, Gallego L, Sanchez-Gonzalez J, Perugorria MJ, Asensio JI, Larburu S, Garmendia M, Larzabal M, Portillo MP, Aguirre L, Banales JM.

BMC MED. 2014; 12: 137. FI: 7.276 (Q1).

Reviews

Published: 6 / 6

Oxygen therapy for acute myocardial infarction.

Cabello JB, Burls A, Emparanza JI, Bayliss S, Quinn T.

Cochrane Database Syst. Rev. 2013; 8: CD007160. FI: 5.785 (Q1).

Reporting quality of survival analyses in medical journals still needs improvement. A minimal requirements proposal.

Abraira MA, Emparanza JI, Pijoan JI, Royuela A, Plana MN, Cano A, Urreta I, Zamora J.

J. Clin. Epidemiol. 2013; 66: 1340-1346. FI: 5.332 (Q1).

Automatic text classification to support systematic reviews in medicine.

Garcia JJ, Pikatza JM, Ubeda M, Ansuategi E.

EXPERT SYST APPL. 2014; 41: 1498-1508. FI: 1.965 (Q1).

Meta-analysis of randomized controlled trials comparing different techniques with primary closure for chronic pilonidal sinus.

Enriquez-Navascues JM, Emparanza JI, Alkorta M, Placer C.

TECH COLOPROCTOL. 2014; 18: 863-872. FI: 1.353 (Q3).

Resumen de las evidencias científicas de la eficacia del ejercicio físico en las enfermedades cardiovasculares.

Aramendi JF, Emparanza JI.

Rev Andal Med Deporte. 2015; 8. 115-129. FI: 0.000 (Q0).

Oxygen therapy for acute myocardial infarction.

Cabello JB, Burls A, Emparanza JI, Bayliss SE, Quinn T.

Cochrane Database Of Systematic Reviews. 2016; 12: -. FI: 6,124 (Q1).

Editorials

Published: 2 / 2

Chronic patient care strategy: role of the emergency services.

Gonzalez-Armengol JJ, Busca Ostolaza P.

Emergencias. 2013; 25: 343-344. FI: 2.578 (Q1).

Clinical teaching in the 21st Century-the curriculum for evidence-based practice.

Cabello JB, Emparanza JI, Burls AJ.

Med. Clin. (Barc). 2013; 141: 221-226. FI: 1.399 (Q2).

Letters

Published: 3 / 3

Regarding emergency department consultations with neurologists.

Busca, P., Miro, O.

Neurologia. 2015; 30: 319-0. FI: 1.381 (Q4).

Mild hepatic iron overload in dysmetabolic hyperferritinemia: MRI may overestimate the liver iron concentration values.

Castiella A, Alustiza JM, Zapata E, EmparanzaJI, Otazua P, Zubiaurre L, Aguirre A.

Ann. Hematol. 2012; 91: 961-0. FI: 2.615 (Q2).

Epidemic nephropathy due to Puumala virus: A case report.

Fuertes-Rodriguez A, Atutxa-Bizkarguenaga L, Aranegui-Lasuen P, Zubia-Olaskoaga F.

Enferm. Infec. Microbiol. Clin. 2014; 32: 472-473. FI: 1.881 (Q3).

Others

Published: 2 / 2

Is MRI becoming the new gold standard for diagnosing iron overload in hemochromatosis and other liver iron disorders?.

Castiella A, Alustiza JM, Zapata E, Emparanza JI.

Imaging Med. 2013; 5: 515-524. FI: 0.000 (Q0).

Intensive multidisciplinary care programme for frail patients.

Urreta I, Aranegui P, Artetxe J, Zubeldia X, Huerta I, Emparanza JI.

EJPCH. 2014; 1: 274-281. FI: 0.000 (Q0).

Projects

Projects

Este grupo no tiene Projects